[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"residual-gastric-contents\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:residual-gastric-contents":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100639017","glp-1-ra-cessation-and-gastric-ultrasound-findings-100639017",false,"NCT07623148","GLP-1 RA Cessation and Gastric Ultrasound Findings","Time-dependent Association Between Cessation of Glucagon-like Peptide-1 Receptor Agonists and Residual Gastric Contents Assessed by Point-of-care Gastric Ultrasound: a Prospective Observational Study","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Patients receiving a glucagon-like peptide-1 receptor agonist.\n* Patients scheduled for elective non-cardiac surgery requiring general anesthesia.\n* Patients able to provide written informed consent.\n\nExclusion Criteria:\n\n* Emergency surgery.\n* History of prior gastric surgery.\n* Known gastroparesis or severe gastroesophageal reflux disease.\n* Declined or unable to provide written informed consent.","ALL","19 Years","65 Years",{"count":20,"type":21},186,"ESTIMATED","OBSERVATIONAL","This prospective observational study will evaluate the association between the time interval since the last dose of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and residual gastric contents before elective surgery. Adult patients receiving GLP-1 RAs and scheduled for elective non-cardiac surgery under general anesthesia will undergo preoperative point-of-care gastric ultrasound. The study will assess whether longer GLP-1 RA cessation intervals are associated with lower ultrasound-estimated gastric volume and a lower frequency of high-risk gastric contents. Body mass index will also be evaluated as a potential modifier of this association.",[25,26],"Residual Gastric Contents","Delayed Gastric Emptying","RECRUITING","2026-06-24",{"date":30,"type":31},"2026-06-26","ACTUAL",{"date":33,"type":21},"2026-07-04",{"date":35,"type":21},"2026-08-20",{"name":37,"class":38},"Wonkwang University Hospital","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":4},"100637351","effect-of-miralax-npo-time-on-residual-gastric-volumes-and-bowel-preparation-100637351","NCT07616908","Effect of Miralax NPO Time on Residual Gastric Volumes and Bowel Preparation","Inclusion Criteria:\n\n* Patients undergoing both EGD and colonoscopy\n* Use of Miralax for cleanout\n* Patients \\\u003C19 years old\n\nExclusion Criteria:\n\n* Patients with a history of delayed gastric emptying (eg diabetic, GLP-1 intake)\n* Patients with a history of gastric sleeve surgery\n* Use of Golytely for cleanout\n* Emergent EGD\u002Fcolonoscopies\n* EGD\u002Fcolonoscopies for foreign body removal and\u002For decompression\n* Known neurologic compromise\n* Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal obstruction, ileus, bowel perforation, toxic colitis, toxic megacolon, swallowing difficulties\n* Pre-existing electrolyte derangements\n* Allergy to Miralax","18 Years",{"count":48,"type":21},200,"INTERVENTIONAL",[51],"NA","The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (1-4 hours) prior to anesthesia induction.",[25,54],"Polyethylene Glycol",[56,57,58,59,60,61,62],"residual gastric volume","miralax","polythylene glycol","gastric POCUS","pediatric","EGD","colonoscopy","NOT_YET_RECRUITING","2026-05-26",{"date":66,"type":31},"2026-06-01",{"date":68,"type":21},"2026-07",{"date":70,"type":21},"2028-06",{"name":72,"class":38},"Stanford University",{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":4,"eligibilityCriteria":79,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":49,"phases":82,"briefSummary":83,"conditions":84,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":95},"100580588","effect-of-fasting-recommendations-among-patients-using-glp-1-receptor-agonists-100580588","NCT06839248","Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists","Effect of Fasting Recommendations on Residual Gastric Contents Among Patients Using Glucagon-like Peptide-1 Receptor Agonists: A Randomised Controlled Trial","Inclusion Criteria:\n\n* Age ≥18 years old at enrolment.\n* Have regularly administered any type of once-weekly GLP-1 RA medication for a period of at least one month prior to randomisation.\n* If allocated to follow standard fasting guidelines, willing to adhere to ASA and ANZCA preoperative fasting requirements. This requires participants to only consume clear liquids up to 2 hours, a light or low calorific meal up to 6 hours, and fasting from fried foods, fatty foods, or meat for at least 8 hours prior to the trial visit.\n* If allocated to follow a 24-hour clear liquid diet, willing to adhere to nothing-by-mouth (NPO) for solids and last intake of clear liquids no less than 2 hours prior to the trial visit.\n* Provide a signed and dated informed consent form for study participation in line with the requirements of the human research ethics committee (HREC) of the study site.\n\nExclusion Criteria:\n\nParticipants meeting any of the following criteria, indicative of abnormal anatomy and not validated by gastric ultrasound, will be excluded from this trial:\n\n* Has a recent history of gastrointestinal bleed within the previous 1 month from enrolment.\n* Has a history of previous lower oesophageal or gastric surgery.\n* Has a known abnormal upper gastrointestinal anatomy, including hiatus hernia or gastric tumours.\n\nIn addition, participants meeting any the of following criteria will be excluded from this trial:\n\n* Participant reports having been previously diagnosed with a clinically significant gastric emptying abnormality such as gastroparesis.\n* Participant reports concomitant use of insulin.\n* Unable to assume the right lateral decubitus position required for gastric ultrasound assessment.\n* Participant has difficulty fully understanding PICF or study materials due to a primary language other than English.",{"count":81,"type":21},154,[51],"The aim of this randomised controlled trial is to determine the effect of a 24-hour clear liquid diet compared to standard fasting guidelines on the proportion of participants who present with increased residual gastric contents during their study visit. It also aims to determine the effect of a 24-hour clear liquid diet compared to standard fasting guidelines on:\n\n* Solid content or thick fluids\n* Patient-reported outcome measures (PROMs), including thirst, hunger, nausea, fatigue, and anxiety.\n* Compliance measures, including adherence with the intervention, time since last oral intake of solid foods, and time since last oral intake of clear liquids.\n\nWe will enrol adults who are currently using any once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) medication. Participants will be allocated in a 1:1 ratio to follow a 24-hour clear liquid diet or standard fasting guidelines prior to attending a study visit where participants will undergo a blinded gastric ultrasound assessment.",[25,85],"Pulmonary Aspiration of Gastric Contents","2026-05-06",{"date":88,"type":31},"2026-05-11",{"date":90,"type":31},"2025-06-20",{"date":92,"type":21},"2027-02-01",{"name":94,"class":38},"St Vincent's Hospital Melbourne",2]